TrialsgrambetaRCTs are beautiful

EVEREST II

2011

Endovascular Valve Edge-to-Edge Repair Study II

In 279 patients with grade 3+/4+ mitral regurgitation, percutaneous MitraClip repair was less effective at reducing death, mitral surgery, or residual MR at 12 months but safer than mitral valve surgery.

Result

Freedom from death, mitral-valve surgery, and 3+/4+ MR at 12 months
Absolute difference
18 points
NNH
6

Absolute difference and NNH are derived from the event rates.

Also reported: Surgery more effective), but MitraClip had far fewer 30-day major adverse events (15% vs 48%, P<0.001).

Original publication
Subtopic
MitraClip
Design
Multicentre RCT (2:1), non-inferiority for efficacy
Relevance
Supporting: context rather than must-know.
Source
Feldman T, et al. N Engl J Med. 2011;364(15):1395-1406.doi 10.1056/NEJMoa1009355

Discussion & critique

Enrolled mostly degenerative MR in good surgical candidates, and residual MR common with the clip. Established MitraClip as safer but less durable, positioning it for high-risk primary MR and later functional MR (COAPT).

Discussed in podcasts